vs
Assertio Holdings, Inc.（ASRT）与Ispire Technology Inc.（ISPR）财务数据对比。点击上方公司名可切换其他公司
Ispire Technology Inc.的季度营收约是Assertio Holdings, Inc.的1.5倍（$20.3M vs $13.5M），Ispire Technology Inc.同比增速更快（-51.5% vs -57.9%），过去两年Ispire Technology Inc.的营收复合增速更高（-17.8% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Ispire科技是一家专注于先进雾化硬件及配套耗材研发、生产与销售的全球化科技企业，主要服务尼古丁及合法大麻消费市场，下设硬件、品牌大麻产品两大核心业务板块，覆盖北美、欧洲、亚太等核心市场，为B端合作商及终端用户提供合规创新的雾化解决方案。
ASRT vs ISPR — 直观对比
营收规模更大
ISPR
是对方的1.5倍
$13.5M
营收增速更快
ISPR
高出6.4%
-57.9%
两年增速更快
ISPR
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $20.3M |
| 净利润 | — | $-6.6M |
| 毛利率 | — | 17.1% |
| 营业利润率 | -86.7% | -33.9% |
| 净利率 | — | -32.5% |
| 营收同比 | -57.9% | -51.5% |
| 净利润同比 | — | 17.4% |
| 每股收益（稀释后） | $-4.54 | $-0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTISPR
| Q4 25 | $13.5M | $20.3M | ||
| Q3 25 | $49.5M | $30.4M | ||
| Q2 25 | $29.2M | $20.1M | ||
| Q1 25 | $26.5M | $26.2M | ||
| Q4 24 | $32.2M | $41.8M | ||
| Q3 24 | $29.2M | $39.3M | ||
| Q2 24 | $31.1M | $37.3M | ||
| Q1 24 | $32.4M | $30.0M |
净利润ASRTISPR
| Q4 25 | — | $-6.6M | ||
| Q3 25 | $11.4M | $-3.3M | ||
| Q2 25 | $-16.4M | $-14.8M | ||
| Q1 25 | $-13.5M | $-10.9M | ||
| Q4 24 | — | $-8.0M | ||
| Q3 24 | $-2.9M | $-5.6M | ||
| Q2 24 | $-3.7M | $-3.5M | ||
| Q1 24 | $-4.5M | $-5.9M |
毛利率ASRTISPR
| Q4 25 | — | 17.1% | ||
| Q3 25 | — | 17.0% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | — | 18.2% | ||
| Q4 24 | — | 18.5% | ||
| Q3 24 | — | 19.5% | ||
| Q2 24 | — | 28.3% | ||
| Q1 24 | — | 20.4% |
营业利润率ASRTISPR
| Q4 25 | -86.7% | -33.9% | ||
| Q3 25 | 23.2% | -8.9% | ||
| Q2 25 | -27.5% | -72.7% | ||
| Q1 25 | -50.0% | -40.4% | ||
| Q4 24 | -41.9% | -17.6% | ||
| Q3 24 | -10.4% | -13.4% | ||
| Q2 24 | -11.6% | -9.2% | ||
| Q1 24 | -13.4% | -18.8% |
净利率ASRTISPR
| Q4 25 | — | -32.5% | ||
| Q3 25 | 23.1% | -10.7% | ||
| Q2 25 | -56.0% | -73.4% | ||
| Q1 25 | -51.1% | -41.5% | ||
| Q4 24 | — | -19.1% | ||
| Q3 24 | -10.0% | -14.2% | ||
| Q2 24 | -11.8% | -9.4% | ||
| Q1 24 | -13.9% | -19.7% |
每股收益（稀释后）ASRTISPR
| Q4 25 | $-4.54 | $-0.12 | ||
| Q3 25 | $0.11 | $-0.06 | ||
| Q2 25 | $-0.17 | $-0.26 | ||
| Q1 25 | $-0.14 | $-0.19 | ||
| Q4 24 | $-3.28 | $-0.14 | ||
| Q3 24 | $-0.03 | $-0.10 | ||
| Q2 24 | $-0.04 | $-0.07 | ||
| Q1 24 | $-0.05 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $17.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $-7.7M |
| 总资产 | $267.0M | $84.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTISPR
| Q4 25 | $63.4M | $17.6M | ||
| Q3 25 | $93.4M | $22.7M | ||
| Q2 25 | $98.2M | $24.4M | ||
| Q1 25 | $87.3M | $23.5M | ||
| Q4 24 | $100.1M | $34.4M | ||
| Q3 24 | $88.6M | $37.7M | ||
| Q2 24 | $88.4M | $35.1M | ||
| Q1 24 | $80.7M | $39.5M |
总债务ASRTISPR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTISPR
| Q4 25 | $94.0M | $-7.7M | ||
| Q3 25 | $105.8M | $-1.8M | ||
| Q2 25 | $93.3M | $604.7K | ||
| Q1 25 | $108.5M | $14.8M | ||
| Q4 24 | $121.1M | $24.2M | ||
| Q3 24 | $130.5M | $30.7M | ||
| Q2 24 | $132.2M | $34.5M | ||
| Q1 24 | $134.5M | $35.9M |
总资产ASRTISPR
| Q4 25 | $267.0M | $84.4M | ||
| Q3 25 | $319.8M | $96.4M | ||
| Q2 25 | $273.8M | $102.2M | ||
| Q1 25 | $286.4M | $115.7M | ||
| Q4 24 | $284.7M | $132.0M | ||
| Q3 24 | $276.0M | $129.0M | ||
| Q2 24 | $279.4M | $122.6M | ||
| Q1 24 | $282.0M | $108.0M |
负债/权益比ASRTISPR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $-4.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-4.0M |
| 自由现金流率自由现金流/营收 | — | -19.9% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-14.2M |
8季度趋势，按日历期对齐
经营现金流ASRTISPR
| Q4 25 | $-30.0M | $-4.0M | ||
| Q3 25 | $-4.8M | $-1.2M | ||
| Q2 25 | $19.1M | $4.7M | ||
| Q1 25 | $-12.5M | $-12.5M | ||
| Q4 24 | $11.5M | $-3.2M | ||
| Q3 24 | $-35.0K | $3.6M | ||
| Q2 24 | $7.4M | $-1.4M | ||
| Q1 24 | $7.5M | $3.4M |
自由现金流ASRTISPR
| Q4 25 | — | $-4.0M | ||
| Q3 25 | — | $-1.2M | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | — | $-12.7M | ||
| Q4 24 | — | $-3.2M | ||
| Q3 24 | — | $3.3M | ||
| Q2 24 | — | $-2.2M | ||
| Q1 24 | — | $3.3M |
自由现金流率ASRTISPR
| Q4 25 | — | -19.9% | ||
| Q3 25 | — | -3.9% | ||
| Q2 25 | — | 18.6% | ||
| Q1 25 | — | -48.4% | ||
| Q4 24 | — | -7.7% | ||
| Q3 24 | — | 8.5% | ||
| Q2 24 | — | -5.9% | ||
| Q1 24 | — | 10.9% |
资本支出强度ASRTISPR
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 0.3% |
现金转化率ASRTISPR
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
ISPR
暂无分部数据
